← Back to Clinical Trials
Recruiting NCT06633458

Adolescent Psychiatry Inpatients: Self-reported Parent-adolescent Communication Quality and Treatment Outcome

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Mental Disorder in Adolescence
Sponsor Universitätsklinikum Hamburg-Eppendorf
Study Type OBSERVATIONAL
Phase N/A
Enrollment 60
Sex ALL
Min Age 14 Years
Max Age 17 Years
Start Date 2024-07-08
Completion 2026-07-07

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The quality of parent-adolescent communication has been found to be associated with adolescent mental health. However, little is known about the association of parent-adolescent communication and adolescent mental health in the context of psychiatry inpatient treatment. This study aims to find out whether self-reported parent-adolescent communication quality at the time of admission to psychiatry predicts the treatment outcome in terms of symptom reduction 6 months later in an adolescent inpatient sample. It also aims to track changes in adolescent self-reported communication quality in the course of inpatient treatment and afterwards (2, 4 and 6 months after admission) to see whether improvement predicts treatment outcome, with treatment outcome being defined as symptom reduction to baseline. As a secondary endpoint, it will be assessed whether a placement of the adolescent outside the family was considered during treatment and whether self-reported communication quality at the time of admission predicts the consideration of placement outside the family.

Eligibility Criteria

Inclusion Criteria: * Admission to inpatient care unit of the adolescent psychiatry at the University Medical Center Hamburg-Eppendorf. Exclusion Criteria: * Severe symptom burden at admission * Lack of knowledge of the German language.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}